Provided by Tiger Trade Technology Pte. Ltd.

Dyadic International, Inc.

0.5551
-0.0590-9.61%
Post-market: 0.55510.00000.00%16:10 EDT
Volume:258.29K
Turnover:149.03K
Market Cap:22.24M
PE:-2.61
High:0.6370
Open:0.6196
Low:0.5127
Close:0.6141
52wk High:1.60
52wk Low:0.5127
Shares:40.06M
Float Shares:29.89M
Volume Ratio:1.95
T/O Rate:0.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2129
EPS(LYR):-0.2257
ROE:-2826.92%
ROA:-62.99%
PB:-9.32
PE(LYR):-2.46

Loading ...

Dyadic International Q1 EPS $(0.05) Misses $(0.04) Estimate, Sales $1.111M Beat $900.000K Estimate

Benzinga Earnings
·
May 14

Dyadic International, Inc. Q1 EPS USD -0.05

THOMSON REUTERS
·
May 14

Press Release: Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress

Dow Jones
·
May 14

Dyadic International Inc expected to post a loss of 4 cents a share - Earnings Preview

Reuters
·
May 12

Dyadic International announces virtual annual shareholder meeting

Reuters
·
May 02

Dyadic receives Nasdaq notice for failing continued listing financial requirements

Reuters
·
Mar 30

Dyadic International, Inc. FY EPS USD -0.23

THOMSON REUTERS
·
Mar 26

Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress

GlobeNewswire
·
Mar 26

Dyadic International Q4 EPS $(0.06) Misses $(0.04) Estimate, Sales $565.526K Miss $1.343M Estimate

Benzinga Earnings
·
Mar 26

Dyadic International FY2025 net loss widens 26.68% to $7.36 million; revenue drops 11.71% to $3.09 million

Reuters
·
Mar 26

Dyadic International Inc expected to post a loss of 4 cents a share - Earnings Preview

Reuters
·
Mar 24

Dyadic Applied BioSolutions signs OEM distribution agreement with IBT Bioservices

Reuters
·
Mar 16

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership With Ibt Bioservices

THOMSON REUTERS
·
Mar 16

Dyadic International to report full-year 2025 results and host conference call

Reuters
·
Mar 12

Dyadic and Fermbox Bio Launch Animal-Origin-Free Recombinant DNase I (RNase-Free)

Reuters
·
Mar 04

Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (HSIC), Dyadic International (DYAI) and Bioventus (BVS)

TIPRANKS
·
Mar 02

Dyadic Applied BioSolutions and Inzymes ApS Plan 2026 Launch of Non-Animal Chymosin

Reuters
·
Mar 02

Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin

GlobeNewswire
·
Feb 17